BioCryst Pharmaceuticals Inc (BCRX): Weighted Average Diluted Shares
218.58M
Year ended 2025-12-31
+5.5%
3-year compound annual growth
+5.5%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 218.58M | +5.7% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 206.70M | +7.5% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 192.20M | +3.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | 185.91M | +3.8% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | 179.12M | +7.1% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | 167.27M | n/c | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | 115.60M | +12.0% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | 103.19M | +22.2% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | 84.45M | +14.6% | 2020-03-13, From 2017-01-01 |
| 2016-12-31 | 73.70M | +1.1% | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | 72.90M | +9.2% | 2018-03-12, From 2015-01-01 |
| 2014-12-31 | 66.77M | +20.9% | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | 55.22M | n/a | 2016-02-26, From 2013-01-01 |